Health Catalyst, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Health Catalyst, Inc. on June 14, 2023. The filing details the voting outcomes for three specific proposals presented to shareholders.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and shareholder voting results.
Material Changes and Voting Results
Shareholders voted on three proposals with the following outcomes:
- Proposal 1 (Election of Directors): Stockholders elected two Class I directors for a three-year term.
- Anita V. Pramoda: 30,037,200 votes for; 12,313,217 votes withheld.
- S. Dawn Smith: 30,403,681 votes for; 11,946,736 votes withheld.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2023.
- Votes For: 47,292,765
- Votes Against: 108,336
- Abstentions: 5,674
- Proposal 3 (Executive Compensation): Stockholders approved the advisory, non-binding vote to approve the compensation of Named Executive Officers.
- Votes For: 40,672,307
- Votes Against: 1,663,691
- Abstentions: 14,419
Voting Participation: Of 56,259,662 shares entitled to vote, 46,806,678 shares were present or represented by proxy.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of voting results.
Key Facts for Investor Verification
- Verify the specific terms of the executive compensation plan approved in Proposal 3 by reviewing the definitive proxy statement filed on April 27, 2023.
- Confirm the tenure and responsibilities of the newly elected directors, Anita V. Pramoda and S. Dawn Smith, whose terms expire at the 2026 annual meeting.
- Note the significant number of votes withheld for the director elections (approximately 22% of votes cast for each director), which may warrant further review of shareholder sentiment regarding the board.